Future perspectives in Myelodysplastic Syndrome

被引：0
|
作者：
Stehle, Gregor [1 ]
机构：
[1] Univ Spital Basel, Zentrum Stammzellentransplantat, Hamatol, Petersgraben 4, CH-4031 Basel, Switzerland
来源：
THERAPEUTISCHE UMSCHAU | 2022年 / 79卷 / 02期
关键词：
PROGNOSTIC SCORING SYSTEM; RISK MDS; AZACITIDINE; MUTATIONS; LEUKEMIA; EFFICACY; ALPHA;
D O I：
10.1024/0040-5930/a001336
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In the next years the role of molecular genetics will increase in diagnosis, prognosis and therapy of MDS. In the treatment of low risk MDS anemia remains the biggest challgenge. In the treatment of high risk MDS new promising drugs are entering the field and open the possibility of combination therapies. Inclusion into interventional and observational studies is of great importance.
引用
收藏
页码：115 / 118
页数：4
相关论文
共 50 条
  • [1] Thalidomide therapy for myelodysplastic syndromes: current status and future perspectives
    Musto, P
    [J]. LEUKEMIA RESEARCH, 2004, 28 (04) : 325 - 332
  • [2] Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine
    Chanias, Ioannis
    Stojkov, Kristina
    Stehle, Gregor Th.
    Daskalakis, Michael
    Simeunovic, Helena
    Njue, Linet Muthoni
    Schnegg-Kaufmann, Annatina S.
    Porret, Naomi A.
    Allam, Ramanjaneyulu
    Rao, Tata Nageswara
    Benz, Rudolf
    Ruefer, Axel
    Schmidt, Adrian
    Adler, Marcel
    Rovo, Alicia
    Balabanov, Stefan
    Stuessi, Georg
    Bacher, Ulrike
    Bonadies, Nicolas
    [J]. CANCERS, 2021, 13 (13)
  • [3] Novel Approaches and Future Directions in Myelodysplastic Syndrome Treatment
    Bewersdorf, Jan Philipp
    Xie, Zhuoer
    Zeidan, Amer M.
    [J]. CANCER JOURNAL, 2023, 29 (03): : 195 - 202
  • [4] Brugada syndrome: update and future perspectives
    Marsman, E. Madelief J.
    Postema, Pieter G.
    Remme, Carol Ann
    [J]. HEART, 2022, 108 (09) : 668 - +
  • [5] The future of myelodysplastic syndrome-patient priorities and outcomes that matter
    Poynton, Matthew
    Gilmour-Hamilton, Catriona
    Dale-Harris, Isabella
    Clarke, Evelyn
    Stanworth, Simon
    Murphy, Mike
    Roy, Noemi
    [J]. FRONTIERS IN MEDICINE, 2023, 10
  • [6] Past, present and future in low-risk myelodysplastic syndrome
    Toprak, Selami Kocak
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [7] The current and future role of stem cells in myelodysplastic syndrome therapies
    Kobbe, Guido
    Schroeder, Thomas
    Haas, Rainer
    Germing, Ulrich
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (05) : 411 - 422
  • [8] The metabolic syndrome: future perspectives and resulting benefits
    Hanefeld, M.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (48) : S236 - S239
  • [9] Cardiorenal syndrome—current understanding and future perspectives
    Branko Braam
    Jaap A. Joles
    Amir H. Danishwar
    Carlo A. Gaillard
    [J]. Nature Reviews Nephrology, 2014, 10 : 48 - 55
  • [10] Hepatorenal syndrome: Current concepts and future perspectives
    Jung, Chan-Young
    Chang, Jai Won
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (04) : 891 - 908
12345